Nasopharyngeal Carcinoma Clinical Trials Database - Free Access to 325 Studies
Access comprehensive clinical trial information for Nasopharyngeal Carcinoma through Pure Global AI's free database. This collection includes 325 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 86 trials are actively recruiting participants.
Research for Nasopharyngeal Carcinoma is being conducted in China, Taiwan, Singapore and 7+ other countries. Leading sponsors include Sun Yat-sen University and Zhejiang Cancer Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma
Individualized Elective Neck Irradiation in NPC Patients
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
GNT Induction Treatment in Locally Advanced NPC
Pure Global AI provides free access to 325 clinical trials studying Nasopharyngeal Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Sun Yat-sen University, Zhejiang Cancer Hospital, Fudan University, among others.